Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pacs (PACS) Shares Outstanding (Weighted Average) (2023 - 2025)

Pacs (PACS) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $156.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 6.49% to $156.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $156.2 million through Dec 2025, up 6.49% year-over-year, with the annual reading at $156.2 million for FY2025, 6.49% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $156.2 million in Q4 2025 for Pacs, roughly flat from $156.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $156.6 million in Q3 2025 to a low of $128.7 million in Q1 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $142.2 million across 3 years, with a median of $142.9 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): changed 0.0% in 2024 and later grew 20.55% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $128.7 million in 2023, then rose by 13.94% to $146.7 million in 2024, then rose by 6.49% to $156.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PACS at $156.2 million in Q4 2025, $156.6 million in Q3 2025, and $155.8 million in Q2 2025.